MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

04 Nov 2023 Evaluate
A decrease in the sales to Rs. 396.54 millions was observed for the quarter ended September 2023. The sales stood at Rs. 476.91 millions during the similar quarter previous year.Profit after Tax for the quarter ended September 2023 saw a decline of -32.93% from Rs. 186.99 millions to Rs. 125.42  millions.Operating Profit reported a sharp decline to 178.20 millions from 257.98 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 396.54 476.91 -16.85 892.42 926.35 -3.66 1489.73 1148.54 29.71
Other Income 10.01 13.96 -28.30 20.76 28.19 -26.36 60.24 40.50 48.74
PBIDT 178.20 257.98 -30.92 424.01 500.00 -15.20 802.42 620.96 29.22
Interest 0.51 0.42 21.43 0.76 1.04 -26.92 2.01 8.28 -75.72
PBDT 177.69 257.56 -31.01 423.25 498.96 -15.17 800.41 612.68 30.64
Depreciation 8.84 5.79 52.68 16.33 11.49 42.12 25.76 22.33 15.36
PBT 168.85 251.77 -32.93 406.92 487.47 -16.52 774.65 590.35 31.22
TAX 43.43 64.78 -32.96 104.29 122.77 -15.05 194.96 154.10 26.52
Deferred Tax 1.11 2.66 -58.27 2.07 0.74 179.73 2.55 0.72 254.17
PAT 125.42 186.99 -32.93 302.63 364.70 -17.02 579.69 436.25 32.88
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 44.94 54.09 -16.92 47.51 53.98 -11.97 53.86 54.07 -0.37
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..